Open Access

Clinical efficacy of γ‑globulin combined with dexamethasone and methylprednisolone, respectively, in the treatment of acute transverse myelitis and its effects on immune function and quality of life

  • Authors:
    • Peiquan Wang
    • Suhua Zhang
    • Hongchun Lv
    • Gang Qiao
    • Xiaodong Zhong
    • Hua Li
    • Lili Zhang
  • View Affiliations

  • Published online on: September 18, 2020     https://doi.org/10.3892/etm.2020.9234
  • Article Number: 104
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Effects of γ‑globulin combined with dexamethasone or methylprednisolone in the treatment of acute transverse myelitis (ATM) were investigated. A retrospective analysis of medical records from 136 ATM patients admitted to Linzi District People's Hospital from July 2014 to September 2017 was performed. Patients treated with dexamethasone combined with γ‑globulin were in group A (66 cases), and patients treated with methylprednisolone combined with γ‑globulin were in group B (70 cases). Clinical efficacy, recovery time of bone marrow function and incidence rate of adverse reactions were analyzed and compared between the two groups. T‑lymphocyte subsets in peripheral blood of both groups were detected by Flow cytometry. Quality of life of patients was assessed by the Quality of Life Scale (SF‑36) developed by the American Institute of Medicine. Time of sensory recovery, self‑walking, improving muscle strength at two levels and urination recovery after treatment in group B were significantly shorter than those in group A (P<0.001); effective rate of treatment in group B was significantly higher than that in group A (P<0.05); incidence rate of adverse reactions in group B was significantly lower than that in group A (P<0.05); ratios of CD3+, CD4+, CD8+ cells and CD4+/CD8+ in peripheral blood of group A and group B after treatment were significantly higher than those before treatment (P<0.05); scores of general health (GH), physical function (PF), role physical (RP), body pain (BP), social function (SF), role emotional (RE), mental health (MH) and vitality (VT) in group B after treatment were significantly higher than those in group A (P<0.05). In conclusion, clinical efficacy of γ‑globulin combined with methylprednisolone in the treatment of ATM patients shows definitely fewer adverse reactions, which can improve their immune function and quality of life.
View Figures
View References

Related Articles

Journal Cover

November-2020
Volume 20 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang P, Zhang S, Lv H, Qiao G, Zhong X, Li H and Zhang L: Clinical efficacy of &gamma;‑globulin combined with dexamethasone and methylprednisolone, respectively, in the treatment of acute transverse myelitis and its effects on immune function and quality of life. Exp Ther Med 20: 104, 2020.
APA
Wang, P., Zhang, S., Lv, H., Qiao, G., Zhong, X., Li, H., & Zhang, L. (2020). Clinical efficacy of &gamma;‑globulin combined with dexamethasone and methylprednisolone, respectively, in the treatment of acute transverse myelitis and its effects on immune function and quality of life. Experimental and Therapeutic Medicine, 20, 104. https://doi.org/10.3892/etm.2020.9234
MLA
Wang, P., Zhang, S., Lv, H., Qiao, G., Zhong, X., Li, H., Zhang, L."Clinical efficacy of &gamma;‑globulin combined with dexamethasone and methylprednisolone, respectively, in the treatment of acute transverse myelitis and its effects on immune function and quality of life". Experimental and Therapeutic Medicine 20.5 (2020): 104.
Chicago
Wang, P., Zhang, S., Lv, H., Qiao, G., Zhong, X., Li, H., Zhang, L."Clinical efficacy of &gamma;‑globulin combined with dexamethasone and methylprednisolone, respectively, in the treatment of acute transverse myelitis and its effects on immune function and quality of life". Experimental and Therapeutic Medicine 20, no. 5 (2020): 104. https://doi.org/10.3892/etm.2020.9234